• Skip to main content
  • Skip to footer
Log Out

Oncology Resource Group

Oncology Competitive Intelligence Leaders

  • ONCrg Full Support™
    • ONCrg Conference™
    • ONCrg Pipeline Strategies™
    • ONCrg Sentinel™
    • ONCrg Advisory™
  • Oncology Coverage
        • SOLID TUMORS
          • Bladder
          • Breast
          • Colorectal
          • Endometrial
          • Esophageal
          • Gastric
          • Gliomas
          • HCC
          • HNSCC
          • Melanoma
          • NSCLC
          • Ovarian
          • Pancreatic
          • Prostate
          • RCC
          • SCLC
          • STS
        • IMMUNO-ONCOLOGY
          • Emerging IO
          • Late Stage IO
        • MOAs
          • ADC
          • Cell Therapies
          • DDR
        • HEMATOLOGIC MALIGNANCIES
          • ALL
          • AML
          • CLL
          • MDS
          • MM
          • MPNs
          • NHL
        • CONFERENCES
          • ASCO GI
          • ASCO GU
          • SGO
          • ELCC
          • AACR
          • ASCO
          • EHA
          • ICML
          • WCLC
          • ESMO
          • SITC
          • SNO
          • ASH
          • SABCS
  • About ONCrg
    • About ONCrg
    • Our Team
    • Careers
    • Contact
    • Home
  • Contact
  • Login

Main Content

Oncology
Competitive Intelligence
expert, content-focused insights

What We Deliver

ONCrg Advisory - ONCrg Conference
ONCrg-Conference
ONCrg-Advisory-Sentinel
ONCrg-Sentinel
ONCrg-Advisory-Pipelines
ONCrg-Pipeline-Strategies
ONCrg Pyramid
ONCrg Conference™
ONCrg Conference™ reports are best-in-class CI resources for medical conferences from Ph.D. analysts with extensive subject matter expertise.
ONCrg Pipeline Strategies™
ONCrg Pipeline Strategies™ reports are expert analyses of competitive landscapes with detailed product profiles, benchmarks, and treatment algorithms.
ONCrg Sentinel™
ONCrg Sentinel™ reports provide expert CI support year-round with succinct but comprehensive analyses of new data releases and market changes.
ONCrg Advisory™
ONCrg Advisory™ – support from expert authors.

Who We Are


ONCrg Team
plus
ONCrg Experience
equals
ONCrg IO Reports
More
More
More
ONCrg Team
More

ONCrg Experience
More

ONCrg IO Reports
More

Who We Serve

ONCrg Conference Coverage

Completed or Coming Soon

ASCO GI 2023
January 19-21, 2023
San Francisco, CA

Learn More
ASCO GU 2023
February 16-18, 2023
San Francisco, CA

Learn More
SGO 2023
March 25-28, 2023
Tampa, FL

Learn More
ELCC 2023
March 29-April 1, 2023
Copenhagen, Denmark

Learn More
AACR 2023
April 14-19, 2023
Orlando, FL

Learn More
ASCO 2023
June 2-6, 2023
Chicago, IL

Learn More
EHA 2023
June 8-11, 2023
Frankfurt, Germany

Learn More
ICML 2023
June 13-17, 2023
Lugano, Switzerland

Learn More
WCLC 2023
September 9-12, 2023
Singapore

Learn More
ESMO 2023
October 20-24, 2023
Madrid, Spain

Learn More
SITC 2023
November 1-5, 2023
San Diego, CA

Learn More
SNO 2023
November 15-19, 2023
Vancouver, Canada

Learn More
SABCS 2023
December 5-9, 2023
San Antonio, TX

Learn More
ASH 2023
December 9-12, 2023
San Diego, CA

Learn More

OUR COVERAGE

We earn a wide range of endorsements

“My team here loves the work ONCrg does – we are constantly pulling these reports up for various reasons and they are so AWESOME! Thanks so much!” 

Senior Associate Director, Oncology Field Based Medicine
  • Large Pharma - EU

“Wow, very helpful and nice.  I appreciate the preview of coming attractions!   Thank you very much, helps my story a lot with this unbiased view of the market…”

Director, New Product Planning 
  • Large Pharma - US

“I have run CI and new products marketing across many therapeutic areas, and have never seen a similar product or frankly one that even comes close in terms of attention to detail, level of depth, true understanding of the analysts and ability to communicate to clients, open lines of communication, etc.“

Director, Business Information
  • Mid-Sized BioPharma - EU

“I have to say, this is one of the best intelligence services I have ever used. You and your team do a great job”

Executive Director, Head of Business Excellence and Operations
  • Large Pharma - US

“What I value most from ONCrg is the unfiltered unbiased view you give irrespective of what manufacturers say. We love the key implications you put together and why they matter”

Interim Head, Oncology
  • Large Pharma - US

“As always you guys hit these reports out of the park!!  These are so great…. for the first time I’m not making data slides post conferences so thank you for that!” 

Medical Science Liaison Oncology
  • Large Pharma - US

“ I really liked your past, present and future perspectives. This is some of the best work I have ever seen from a vendor.” 

VP & Head of Medical & Clinical Affairs
  • Small Biotech - US

“BRAVO!!  Most comprehensive map that I have reviewed for current SOC; and then every MoA and compound in development.  Very Impressive.  My hat is tipped to your team. I will distribute it across to my team and School is in Session.”

Associate Director, Program Lead II - Oncology
  • Large Pharma - US

“Our organization is extremely frugal so we always have budget challenges but your value us extremely good and we love working with you so we absolutely want to continue investing in ONCrg.”

Director, Commercial Planning
  • Large Pharma - US

“These reports are incredibly informative and helpful as we think about our research strategy and drug developments options in these indications. I greatly appreciate you and the ONCrg team’s efforts to generate these reports and summaries.

Director Oncology Discovery
  • Large Pharma - US

“This is great! Until you’ve tried to attend a conference and make sense of what you saw and heard there, you can’t appreciate how hard it is to do it, so this is a really nice way of distilling the information.”

Competitive Intelligence Lead
  • Mid-Sized BioPharma - US

“I have been supporting myeloma brand for 3 years. This level of quality is what I am personally looking for and beyond what typical CI vendors can do….I see you have subject matter experts in each therapeutic area.”

Director, Scientific & Competitive Analysis, Global Oncology BU
  • Large Pharma - US

“ONCrg has really good data and really good analysts, which was not what I found at Big Pharma or Small Pharma”

Senior Director Medical Affairs
  • Small Biotech - US

“I really appreciate working with you and the great support you have provided over the last couple of years! The internal feedback was quite positive: Very clear and precise statements; nice format – holistic and comprehensive” 

Head Scientific Competitive Intelligence Biopharma R&D
  • Large Pharma - EU

“This is an outstanding summary of ASCO GU! We really appreciate all the detailed summaries and implications provided in this report.  The clear insights your team provide continue to be fantastic! We use your upfront slides to convey complicated information to senior leadership.”

Associate Brand Manager, Global Marketing
  • Large Pharma - US

“Wow! This is amazing. Literally exactly what I was looking for. Thanks so much!! You’re the best.” 

Associate Scientific Director, Solid Tumors Oncology Global Medical Affairs
  • Large Pharma - US

“This fully answers my question. This additional information and timely response is also extremely helpful in filling some of the gaps I had as I prepare for upcoming governance meetings.”

Global Commercial Development
  • Large Pharma - US

“My organization relies so heavily on ONCrg. I’m one of the strongest advocates and will continue to be, not just for conferences but across the board. “Our senior managers absolutely love the competitive landscape diagrams in your Pipeline Strategies reports.”

Scientific Director, Oncology; US Medical Affairs
  • Large Pharma - US

“I love the tumor specific reports that give me  a lay of the land, are easily digestible. I really appreciate the implications and commentary in each report.”

Vice President, Therapeutic Area Head - Solid Tumor
  • Large Pharma - US

“I know that many really like what you’re doing…everyone was thankful and found the reports very helpful”

 Senior Manager Market Research
  • Mid-Sized BioPharma - US

I have always found the ONCrg reports to be valuable and to have evolved in sync with the changing times in oncology (not all vendors have).”

Director, New Product Planning
  • Mid-Sized BioPharma - US

“The fact that ONCrg got our vaccine right is proof that we have done our research”. Also, there were 3 things I picked up from your vaccine presentation that I didn’t know. Quite helpful.”

Chief Medical Officer
  • Small Biotech - EU

“The way you do implications was exactly how I would like them to be delivered from a company covering them at ESMO” 

Senior Director, Product Strategy & Market Intelligence
  • Small Biotech - US

“Thank you so much for the Onc-rg reports that your team provides.  These reports are very helpful to the field medical team!”  

Associate Director, Medical Science Liaison - Oncology
  • Large Pharma - US

“Thanks team, this is making my life easier already”

Global Oncology New Product Planning
  • Large Pharma - US

“I am quite impressed with the approach that you have taken to developing market assessments based on clinical trials reporting in a variety of settings. I appreciate the access to the meeting trials compendia in my core areas of interest”

Group Medical Director Oncology Clinical Development 
  • Large Pharma - US

“Thank you for the excellent work that you have delivered and for the wonderful partnership we have enjoyed.”

Head, R&D and Commercial Insights, Global Oncology Franchise
  • Large Pharma - US

“I find the depth of information and their very succinct explanations to be extremely well written and easy to read, so this would enable me to stay aware of compounds moving up the ladder. Great work”

Senior Manager, Medical Affairs, Medical Communications
  • Large Pharma - US

“I assume you have many clients, so I really appreciate how you can customize the coverage to our needs, I don’t know how you do it.”

Senior Medical Director, Oncology Medical Affairs - US
  • Large Pharma - US

“Take the opportunity to check out the “Implications” box on each slide. This agency is excellent at providing valuable context for new data. We will get these reports once a month as well as some really helpful supplementary reports.” 

Head of Global Marketing and Commercial Strategy
  • Mid-Sized BioPharma - EU

“Thanks for the support and fantastic customer service.” 

Ex Dir, Head of Business Intelligence & Commercial Operations
  • Mid-Sized BioPharma - US

“Thanks for all the ASCO updates in RCC, breast, IO, etc.  They really are terrific and help tremendously with our MA debrief…”

Senior Medical Science Liaison
  • Small Biotech - US
ALREADY A CLIENT? CLICK HERE TO REGISTER.

    Information and Sample Requests
    To learn more about our reports, services, and CI support, please fill out the form below or call us at 650.485.2626.
    *Please note, we will not share your details outside of our company

    Footer


    ONCrg is a Division of





    ONCrg Full Support™
    ONCrg Conference™
    ONCrg Pipeline Strategies™
    ONCrg Sentinel™
    ONCrg Advisory™

    About ONCrg
    About ONCrg
    Our Team
    Careers
    Contact
    Home Page

    Solid Tumors
    Bladder
    Breast
    Colorectal
    Endometrial
    Esophageal
    Gastric
    Gliomas
    HCC
    HNSCC
    Melanoma
    NSCLC
    Ovarian
    Pancreatic
    Prostate
    RCC
    SCLC
    STS

    Hematologic
    Malignancies

    ALL
    AML
    CLL
    MDS
    MM
    MPNs
    NHL

    Immuno-Onc
    Emerging IO
    Late Stage IO

    MOA Reports
    ADC
    Cell Therapies
    DDR

    Conferences
    ASCO GI
    ASCO GU
    SGO
    ELCC
    AACR
    ASCO
    EHA
    ICML
    WCLC
    ESMO
    SITC
    SNO
    SABCS
    ASH

    ONCrg Full Support™

    ONCrg Conference™
    ONCrg Pipeline Strategies™
    ONCrg Sentinel™
    ONCrg Advisory™

    About ONCrg

    About ONCrg
    Our Team
    Careers
    Contact
    Home Page

    Solid Tumors

    Bladder
    Breast
    Colorectal
    Endometrial
    Esophageal
    Gastric
    Gliomas
    HCC
    HNSCC
    Melanoma
    NSCLC
    Ovarian
    Pancreatic
    Prostate
    RCC
    SCLC
    STS

    Hematologic
    Malignancies

    ALL
    AML
    CLL
    MDS
    MM
    MPNs
    NHL

    Immuno-Onc

    Emerging IO
    Late Stage IO

    MOA Reports

    ADC
    Cell Therapies
    DDR

    Conferences

    ASCO GI
    ASCO GU
    SGO
    ELCC
    AACR
    ASCO
    EHA
    WCLC
    ESMO
    SITC
    SNO
    SABCS
    ASH


    ONCrg is a Division of


    BioPharma Resource Groups
    Michael Reynolds +1 650.485.2626
    CardioVascular Resource Group
    Brooke Blackwelder +1 541.977.1516
    Oncology Resource Group
    Brooke Blackwelder +1 541.977.1516

     

     

    © Copyright 2004-2023 · BioPharma Resource Groups      |      Privacy Policy

    Follow us on LI